Quick Answer
Bio Green Med Solution, Inc. reported Operating Income Loss of -$8.43 million for the year ending 2025.
- Bio Green Med Solution, Inc. showed an increase of +29.8% in Operating Income Loss from 2024 to 2025.
- This data is from Bio Green Med Solution, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: -$3.80 million | Q3 2011: -$3.88 million | Q1 2012: -$3.12 million | Q2 2012: -$3.81 million | Q3 2012: -$3.52 million | Q1 2013: -$4.05 million | Q2 2013: -$4.15 million | Q3 2013: -$5.80 million | Q1 2014: -$5.41 million | Q2 2014: -$5.58 million | Q3 2014: -$5.67 million | Q1 2015: -$5.30 million | Q2 2015: -$3.62 million | Q3 2015: -$3.39 million | Q1 2016: -$3.74 million | Q2 2016: -$3.76 million | Q3 2016: -$3.48 million | Q1 2017: -$2.69 million | Q2 2017: -$2.49 million | Q3 2017: -$2.11 million | Q1 2018: -$2.16 million | Q2 2018: -$2.47 million | Q3 2018: -$2.46 million | Q1 2019: -$2.20 million | Q2 2019: -$2.34 million | Q3 2019: -$2.35 million | Q1 2020: -$2.42 million | Q2 2020: -$2.47 million | Q3 2020: -$2.57 million | Q1 2021: -$4.31 million | Q2 2021: -$6.10 million | Q3 2021: -$6.00 million | Q1 2022: -$6.56 million | Q2 2022: -$5.79 million | Q3 2022: -$6.47 million | Q1 2023: -$7.32 million | Q2 2023: -$5.93 million | Q3 2023: -$6.85 million | Q1 2024: -$4.36 million | Q2 2024: -$3.64 million | Q3 2024: -$2.18 million | Q1 2025: -$5.04 million | Q2 2025: -$1.32 million | Q3 2025: -$992.0 thousand.
- Over the full 17 years of available data (2009 to 2025), Bio Green Med Solution, Inc.'s Operating Income Loss has grown by 54.0%.
- Historical annual values: Fiscal year 2025: -$8.43 million | Fiscal year 2024: -$12.00 million | Fiscal year 2023: -$25.45 million | Fiscal year 2022: -$27.66 million | Fiscal year 2021: -$22.94 million | Fiscal year 2020: -$10.64 million | Fiscal year 2019: -$9.68 million | Fiscal year 2018: -$9.55 million | Fiscal year 2017: -$9.49 million | Fiscal year 2016: -$14.15 million | Fiscal year 2015: -$16.17 million | Fiscal year 2014: -$22.44 million | Fiscal year 2013: -$17.97 million | Fiscal year 2012: -$15.10 million | Fiscal year 2011: -$15.75 million | Fiscal year 2010: -$15.14 million | Fiscal year 2009: -$18.30 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: